Our results reveal that different from usual lung cancer, the serum expression levels of tumor marker CEA and CA199 should be given more attention in the diagnosis, therapeutic monitoring and relapse prediction of primary PEAC, although more studies are needed to validate it. This evidence concerns the gene CEACAM5 and lung cancer.